Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Allogeneic transplantation in malignant lymphoma].

O J Stötzer1, M Schleuning, G Ledderose

  • 1Medizinische Klinik III der Ludwig-Maximilians-Universität München, Grosshadern.

Deutsche Medizinische Wochenschrift (1946)
|October 17, 2001
PubMed
Summary

Allogeneic stem cell transplantation can achieve long-term remissions in advanced lymphoma patients, particularly those with low-grade lymphoma. However, transplant-related mortality remains high, and reduced conditioning intensity did not lower toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Trends of Trait Matching in Avian Frugivory and Its Consequences for the Complementarity and Irreplaceability of Birds.

Ecology letters·2025
Same author

Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions.

Immunobiology·2021
Same author

Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease.

Immunological investigations·2019
Same author

Temporal variation of fungal diversity in a mosaic landscape in Germany.

Studies in mycology·2018
Same author

Sex ratio rather than population size affects genetic diversity in Antennaria dioica.

Plant biology (Stuttgart, Germany)·2018
Same author

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Context:

  • Allogeneic transplantation is a potential treatment for malignant lymphoma.
  • Evaluating transplant outcomes is crucial for refining treatment strategies.

Purpose:

  • To analyze the results of an allogeneic transplant program in advanced lymphoma patients.
  • To evaluate indications for allogeneic stem cell transplantation.

Summary:

  • This retrospective analysis included 56 advanced lymphoma patients (1985-2001). Overall 2-year survival rates were 48% for low-grade NHL/CLL, 9.3% for high-grade NHL, and 25% for Hodgkin's disease.
  • Transplant-related mortality was 33.9% at 1 year. Reduced conditioning intensity did not decrease this mortality.
  • Allogeneic transplantation can induce durable remissions, especially in follicular and other low-grade lymphomas, despite high toxicity.

Related Experiment Videos

Impact:

  • Allogeneic transplantation shows promise for specific lymphoma subtypes, particularly low-grade lymphomas.
  • High transplant-related toxicity necessitates careful patient selection and further research into conditioning regimens.
  • The study highlights the need for ongoing evaluation of allogeneic transplantation efficacy and safety in lymphoma treatment.